Peginterferon lambda for the treatment of outpatients with COVID-19: a phase 2, placebo-controlled randomised trial
Feld et al., The Lancet Respiratory Medicine, doi:10.1016/S2213-2600(20)30566-X (preprint 11/12/2020)
https://c19early.org/feld.html